NM_018343.3:c.1643G>A
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_018343.3(RIOK2):c.1643G>A(p.Ser548Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018343.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIOK2 | ENST00000283109.8 | c.1643G>A | p.Ser548Asn | missense_variant | Exon 10 of 10 | 1 | NM_018343.3 | ENSP00000283109.3 | ||
RIOK2 | ENST00000511293.1 | c.461G>A | p.Ser154Asn | missense_variant | Exon 4 of 4 | 3 | ENSP00000421830.1 | |||
LIX1-AS1 | ENST00000504578.2 | n.574-19931C>T | intron_variant | Intron 3 of 6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152170Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000799 AC: 2AN: 250330 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1459856Hom.: 0 Cov.: 28 AF XY: 0.00000551 AC XY: 4AN XY: 726316 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152170Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74330 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1643G>A (p.S548N) alteration is located in exon 10 (coding exon 10) of the RIOK2 gene. This alteration results from a G to A substitution at nucleotide position 1643, causing the serine (S) at amino acid position 548 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at